Home
Conditions
Myeloproliferative Disorder

Clinical trial condition

Myeloproliferative Disorder

Explore clinical trials studying Myeloproliferative Disorder. Study availability and eligibility vary by location and protocol.

21 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Myeloproliferative Disorder trial results

Recruiting

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

NCT07362225

Conditions: Accelerated Phase MPN, Accelerated Phase Myeloproliferative Neoplasm, Agnogenic Myeloid Metaplasia, +78 more
Locations: MPN Research Foundation Chicago, Illinois, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Recruiting

Cord Blood Transplant in Adults With Blood Cancers

NCT05884333

Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, +26 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Recruiting

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

NCT03852407

Conditions: Acute Lymphoid Leukemia in Remission, Acute Myeloid Leukemia in Remission, Blood Protein Disorders, +33 more
Locations: ZNA Stuivenberg Antwerp, Belgium

AZ Sint Jan Brugge Bruges, Belgium

IJ Bordet Brussels, Belgium

UZ Brussel Brussels, Belgium

View Trial Details

Completed

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

NCT03480360

Conditions: Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +33 more
Locations: Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center Lebanon, New Hampshire, United States

View Trial Details

Completed

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

NCT03434730

Conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +23 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Aprepitant Versus Hydroxyzine in Persistent Aquagenic Pruritus for Patients With Myeloproliferative Neoplasms

NCT03808805

Conditions: Aquagenic Pruritus, Bone Marrow Diseases, Hematologic Diseases, +3 more
Locations: CHRU de Brest - Hôpital Morvan Brest, Brest Cedex, France

Centre Hospitalier de Cornouaille Quimper, France

CHU d'Angers Angers, France

CHU de Caen Caen, France

View Trial Details

Completed

Haplo Peripheral Blood Sct In GVHD Prevention

NCT04473911

Conditions: ALL, AML, Acute Lymphoblastic Leukemia, +37 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)

NCT03149055

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hematologic Malignancy, +6 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.

NCT03869476

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +11 more
Locations: Chu Angers Angers, France

CHRU de Brest - Hôpital Morvan Brest, France

View Trial Details

Completed

Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation

NCT03734601

Conditions: Acute Myeloid Leukemia, B-cell Lymphoma, Bone Marrow Diseases, +33 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Myeloproliferative Disorder

Myeloproliferative Disorder trial results

Related conditions